Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
Sponsor
Cephalon (Industry)
Overall Status
Completed
CT.gov ID
NCT00228605
Collaborator
(none)
500
38
26
13.2
0.5
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl for the potential treatment of breakthrough pain episodes in patients who have chronic noncancer pain.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
An Open-Label 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of OraVescent Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Noncancer Pain
Study Start Date
:
Mar 1, 2005
Actual Study Completion Date
:
May 1, 2007
Outcome Measures
Primary Outcome Measures
- Safety and tolerability when used over a 12-month period for the management of breakthrough pain in opioid tolerant patients []
Secondary Outcome Measures
- Assess the patients' quality of life through questionnaires []
- Assess the patients' overall medication preferences []
- Assess the patients' overall medication performance []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Chronic pain diagnosis
-
Opioid tolerant
-
Has on average 1-4 breakthrough pain episodes per day
Exclusion Criteria:
-
Drug abuse history
-
Cardiopulmonary disease
-
Monoamine oxidase inhibitors (MAOIs)
-
Expected to have surgery to relieve the pain
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | MedSearch | Calera | Alabama | United States | 35040 |
2 | Clinical Research Consultants, Inc. | Hoover | Alabama | United States | 35216 |
3 | Arizona Research Center | Phoenix | Arizona | United States | 85023 |
4 | NEA Clinic | Jonesboro | Arkansas | United States | 72404 |
5 | Lynn Institute of the Rockies | Colorado Springs | Colorado | United States | 80909 |
6 | Radiant Research-Daytona Beach | Daytona Beach | Florida | United States | 32114 |
7 | Advent Clinical Research Centers, Inc. | St. Petersburg | Florida | United States | 33703 |
8 | Gold Coast Research | Weston | Florida | United States | 33331 |
9 | Center for Prospective Outcome Studies, Inc. | Atlanta | Georgia | United States | 30327 |
10 | Advent Clinical Research Centers, Inc. | Atlanta | Georgia | United States | 30342 |
11 | Center for Prospective Outcome Studies, Inc. | Marietta | Georgia | United States | 30060 |
12 | North Fulton Regional Hospital Pain Center | Roswell | Georgia | United States | 30076 |
13 | Carmen Research | Smyrna | Georgia | United States | 30080 |
14 | Orthopedic Health Care | Boise | Idaho | United States | 83702 |
15 | Medisphere Medical Research Center, LLC | Evansville | Indiana | United States | 47714 |
16 | Tri-State Arthritis & Rheumatology Center, LLC | Evansville | Indiana | United States | 47714 |
17 | Iowa Pain Management Clinic, PC | Des Moines | Iowa | United States | 50265 |
18 | Mid-America Physiatrists, PA | Overland Park | Kansas | United States | 66211 |
19 | Capital Clinical Research Associates, LLC | Rockville | Maryland | United States | 20852 |
20 | Brigham Women's Hospital, Attn: Pain Trials Center | Boston | Massachusetts | United States | 02115 |
21 | MedVadis Research | Wellesley Hills | Massachusetts | United States | 02481-2106 |
22 | Medex Healthcare Research Center | St. Louis | Missouri | United States | 63108 |
23 | Radiant Research - St. Louis | St. Louis | Missouri | United States | 63141 |
24 | Clinical Research Center of Nevada | Las Vegas | Nevada | United States | 89104 |
25 | Northshore University Hospital | Beth Page | New York | United States | 11714 |
26 | NYU Pain Management Center | New York | New York | United States | 10016 |
27 | Research Across America | New York | New York | United States | 10022 |
28 | The Lynn Health Science Institute | Oklahoma City | Oklahoma | United States | 73112 |
29 | Southern Oregon Health & Wellness | Medford | Oregon | United States | 97504 |
30 | Clinical Research Center of Reading, LLP | West Reading | Pennsylvania | United States | 19611 |
31 | Healthstar Physicians | Morristown | Tennessee | United States | 37813 |
32 | Biopharma Research Associates | Sugar Land | Texas | United States | 77479 |
33 | Lifetree Clinical Research | Salt Lake City | Utah | United States | 84106 |
34 | Radiant Research | Salt Lake City | Utah | United States | 84107 |
35 | Huntsman Cancer Institute | Salt Lake City | Utah | United States | 84112 |
36 | Pain Management Center | South Burlington | Vermont | United States | 05403 |
37 | Northwest Clinical Research Center | Bellevue | Washington | United States | 98004 |
38 | Rowan Research | Spokane | Washington | United States | 99207 |
Sponsors and Collaborators
- Cephalon
Investigators
- Study Director: Gwendolyn Neibler, DO, Cephalon
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00228605
Other Study ID Numbers:
- C25608/3040/BP/US
First Posted:
Sep 29, 2005
Last Update Posted:
May 9, 2014
Last Verified:
May 1, 2014
Keywords provided by ,
,
Additional relevant MeSH terms: